In this study, based on the present findings, we inferred that HCS could inhibit the progression of advanced pancreatic cancer with liver metastasis through down-regulating the expression of VEGF, MMP-2 and MMP-9. The gene discussed is VEGFA; the disease is familial pancreatic carcinoma.